Skip to main content
. 2021 Jan 15;16:101–111. doi: 10.2147/COPD.S284720

Figure 3.

Figure 3

Prediction of exacerbation outcomes, for patients in the USA, in Study B (A) and Study C (B), using the joint model for prediction developed on Study A, and a 1-month data cut-off. Predicted exacerbation-free probabilities (means and 95% CI, blue) vs Kaplan–Meier estimates (dashed line). The shaded area in (A) denotes additional treatment arms in Study B which was not included in Study A.